openPR Logo
Press release

Investigation announced for Investors in shares of TrueBlue, Inc. (NYSE: TBI) over potential Wrongdoing

09-09-2022 05:28 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in TrueBlue, Inc. (NYSE: TBI) shares over potential wrongdoing at TrueBlue, Inc.

An investigation on behalf of investors in TrueBlue, Inc. (NYSE: TBI) shares over potential wrongdoing at TrueBlue, Inc.

An investigation was announced for investors in NYSE: TBI shares over potential breaches of fiduciary duties by certain directors at TrueBlue, Inc.

Investors who purchased shares of TrueBlue, Inc. (NYSE: TBI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain TrueBlue directors breached their fiduciary duties and caused damage to the company and its shareholders.

Tacoma, WA based TrueBlue, Inc., together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, and Puerto Rico. TrueBlue, Inc. reported that its annual Total Revenue rose from over $1.84 billion in 2020 to over $2.17 billion in 2021, and that its Net Loss of $141.84 million in 2020, to a Net Income of $61.63 million in 2021.

On June 15, 2022, TrueBlue, Inc disclosed that their CEO, Patrick Beharelle has resigned, effective June 14, 2022. The departure of Mr. Beharelle was followed by an investigation, led by outside counsel, into allegations regarding his conduct.

Shares of TrueBlue, Inc (NYSE: TBI) declined from $32.91 per share on October 25, 2021, to as low as $15.77 per share on June 17, 2022.

Those who purchased shares of TrueBlue, Inc. (NYSE: TBI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of TrueBlue, Inc. (NYSE: TBI) over potential Wrongdoing here

News-ID: 2729253 • Views: 222

More Releases from Shareholders Foundation

Exela Technologies, Inc. (NASDAQ: XELA) Investor Notice: Investigation over pote …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Exela Technologies, Inc. Investors who purchased shares of Exela Technologies, Inc. (NASDAQ: XELA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Exela Technologies directors breached their fiduciary duties and caused damage to the company and its shareholders. On March 23, 2020,
Investigation announced for Long-Term Investors in Cavco Industries, Inc. (NASDA …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Cavco Industries, Inc. Investors who purchased shares of Cavco Industries, Inc. (NASDAQ: CVCO) NASDAQ: CVCO shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Cavco Industries directors breached their fiduciary duties and caused damage to the company and
Investigation announced for Investors in Energy Transfer LP (NYSE: ET) over pote …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Energy Transfer LP. Investors who are current long term investors in Energy Transfer LP (NYSE: ET) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: ET stocks follows a lawsuit filed against Energy
Investigation announced for Long-Term Investors in shares of Spero Therapeutics, …
An investigation was announced for current long-term investors in shares of Spero Therapeutics, Inc. (NASDAQ: SPRO) concerning potential breaches of fiduciary duties by certain directors of Spero Therapeutics, Inc.. Investors who are current long term investors in Spero Therapeutics, Inc. (NASDAQ: SPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors

All 5 Releases


More Releases for TrueBlue

CRM in Pharma and Biotech Software Market Significant Demand Foreseen by 2026 | …
Latest Study on Industrial Growth of Global CRM in Pharma and Biotech Software Market 2019-2025. A detailed study accumulated to offer Latest insights about acute features of the CRM in Pharma and Biotech Software market. The report contains different market predictions related to market size, revenue, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also
Pharma & Biotech CRM Software Market By Deployment (On-Premise, Cloud Based (Saa …
The global pharma & biotech CRM software market is estimated to reach USD 8,069 million by 2025 from USD 3,333.8 million in 2019 with a CAGR of 15.9%. Pharma & biotech CRM software plays an important role in the pharma & biotech industry. Such software help in providing better and more reliable support for the pharma & biotech customers and clients by helping and organizing the life sciences data and leveraging
Pharma & Biotech CRM Software Market Size Worth USD 8,069 million by 2025 | 15.9 …
The global pharma & biotech CRM software market is estimated to reach USD 8,069 million by 2025 from USD 3,333.8 million in 2019 with a CAGR of 15.9%. Request Sample Pages https://www.reportocean.com/industry-verticals/sample-request?report_id=BWC135 Pharma & biotech CRM software plays an important role in the pharma & biotech industry. Such software help in providing better and more reliable support for the pharma & biotech customers and clients by helping and organizing the life sciences
CRM in Pharma and Biotech Software Market will touch a new level in upcoming yea …
Global CRM in Pharma and Biotech Software Market Report defines and briefs readers about its products, applications, and specifications. The research lists key companies operating in the global market and also highlights the key changing trends adopted by the companies to maintain their dominance. By using SWOT analysis and Porter's five force analysis tools, the strengths, weaknesses, opportunities, and threats of key companies are all mentioned in the report. All
Global CRM in Pharma and Biotech Software Market 2019 Top Manufacturers are Inov …
Global CRM in Pharma and Biotech Software Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023 released by marketandresearch.biz is a momentous study which delivers a primary overview of the CRM in Pharma and Biotech Software industry covering historic switch, current status, and future projection of the market. This report has the ability to increase significant market worldwide by offering noteworthy knowledge of the market with global market
CRM in Pharma and Biotech Software Market Trends to 2025 by Inova Software, Veev …
The ‘ World CRM in Pharma and Biotech Software Market Research Report 2023 (Covering USA, Europe, China, Japan, India and etc)’ offers detailed coverage of CRM in Pharma and Biotech Software Market industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading CRM in Pharma and Biotech Software Market producers to provide exhaustive coverage